Movatterモバイル変換


[0]ホーム

URL:


DOP2009000145A - DERIVATIVES OF 8-ETINYLXANTINE AS SELECTIVE A2A RECEIVER ANTAGONISTS - Google Patents

DERIVATIVES OF 8-ETINYLXANTINE AS SELECTIVE A2A RECEIVER ANTAGONISTS

Info

Publication number
DOP2009000145A
DOP2009000145ADO2009000145ADO2009000145ADOP2009000145ADO P2009000145 ADOP2009000145 ADO P2009000145ADO 2009000145 ADO2009000145 ADO 2009000145ADO 2009000145 ADO2009000145 ADO 2009000145ADO P2009000145 ADOP2009000145 ADO P2009000145A
Authority
DO
Dominican Republic
Prior art keywords
etinylxantine
selective
derivatives
receiver antagonists
antagonists
Prior art date
Application number
DO2009000145A
Other languages
Spanish (es)
Inventor
Christa Mueller
Joerg Hockemeyer
Nikolay Tzvetkov
Joachim Burbiel
Original Assignee
Sanol Arznei Schwarz Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filedlitigationCriticalhttps://patents.darts-ip.com/?family=41294864&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DOP2009000145(A)"Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from EP06026739Aexternal-prioritypatent/EP1939197A1/en
Application filed by Sanol Arznei Schwarz GmbhfiledCriticalSanol Arznei Schwarz Gmbh
Publication of DOP2009000145ApublicationCriticalpatent/DOP2009000145A/en

Links

Classifications

Landscapes

Abstract

Translated fromSpanish

Se revelan compuestos novedosos de la fórmula general (la) y sus sales, isómeros, diatereómeros o enantiómerosa de los mismos farmacéuticamente aceptables (la) y su uso como medicamentos, por ejemplo, en el tratamiento de trastornos del movimiento relacionados con dopamina.Novel compounds of the general formula (la) and their pharmaceutically acceptable salts, isomers, diatereomers or enantiomers thereof and their use as medicaments are disclosed, for example, in the treatment of dopamine-related movement disorders.

DO2009000145A2006-12-222009-06-17 DERIVATIVES OF 8-ETINYLXANTINE AS SELECTIVE A2A RECEIVER ANTAGONISTSDOP2009000145A (en)

Applications Claiming Priority (2)

Application NumberPriority DateFiling DateTitle
EP06026739AEP1939197A1 (en)2006-12-222006-12-228-ethinylxanthine derivatives as selective A2A receptor antagonists
US94524807P2007-06-202007-06-20

Publications (1)

Publication NumberPublication Date
DOP2009000145Atrue DOP2009000145A (en)2009-07-15

Family

ID=41294864

Family Applications (1)

Application NumberTitlePriority DateFiling Date
DO2009000145ADOP2009000145A (en)2006-12-222009-06-17 DERIVATIVES OF 8-ETINYLXANTINE AS SELECTIVE A2A RECEIVER ANTAGONISTS

Country Status (7)

CountryLink
JP (1)JP2010513353A (en)
KR (1)KR20090094465A (en)
CL (1)CL2007003778A1 (en)
DO (1)DOP2009000145A (en)
MX (1)MX2009006346A (en)
PE (1)PE20081543A1 (en)
TW (1)TW200848421A (en)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
ES2130138T3 (en)*1990-10-181999-07-01Kyowa Hakko Kogyo Kk XANTINA DERIVATIVE.
CA2093403C (en)*1992-04-081999-08-10Fumio SuzukiTherapeutic agent for parkinson's disease
JP2613355B2 (en)*1992-09-281997-05-28協和醗酵工業株式会社 Parkinson's disease treatment
AU6781194A (en)*1993-05-031994-11-21United States Of America, Represented By The Secretary, Department Of Health And Human Services, The8-substituted 1,3,7-trialkyl-xanthine derivatives as a2-selective adenosine receptor antagonists
DE69526822T2 (en)*1994-02-232003-01-23Kyowa Hakko Kogyo K.K., Tokio/Tokyo Xanthine derivatives

Also Published As

Publication numberPublication date
TW200848421A (en)2008-12-16
CL2007003778A1 (en)2009-03-27
MX2009006346A (en)2010-03-03
JP2010513353A (en)2010-04-30
PE20081543A1 (en)2009-01-04
KR20090094465A (en)2009-09-07

Similar Documents

PublicationPublication DateTitle
UY30835A1 (en) 8-ALQUINILXANTINAS AND DERIVATIVES
UY28766A1 (en) ADDITIONAL HETEROPOLYCLIC COMPOUNDS AND THEIR USE AS ANTAGONISTS OF THE METABOTROPIC GLUTAMATE RECEIVER
UY31124A1 (en) DERIVATIVES OF OXIADAZOL AND ITS USE AS POTENTIALS OF THE METABOTROPIC RECEIVER OF GLUTAMATE - 842
UY29781A1 (en) DIAZASPIRO SUBSTITUTE COMPOUNDS, PHARMACEUTICALLY ACCEPTABLE SALTS, PHARMACEUTICAL COMPOSITIONS CONTAINING THE COMPOUNDS OR SALTS, PREPARATION METHODS AND USES
UY31127A1 (en) METABOTROPIC RECEIVER OXYADAZOL LIGANDS FOR GLUTAMATE AND ITS USE AS POTENTIALS - 841
SV2010003662A (en) DERIVATIVES OF AZETIDINE AND CYCLLOBUTANE AS JAK INHIBITORS REF. X-19081
GT200600081A (en) ACETYLENE DERIVATIVES
CR20110077A (en) DIOXA-BICYCLE DERIVATIVES [3.2.1] OCTANO-2,3,4-TRIOL
CR8744A (en) THERAPEUTIC COMPOUNDS
UY29735A1 (en) PIPERAZINAS REPLACED AS ANTAGONISTS OF METABOTROPIC GLUTAMATE RECEPTORS
PA8657501A1 (en) PIPERIDA DERIVATIVES AND THEIR USE AS ANTI-INFLAMMATORY AGENTS
UY30500A1 (en) AZABENCIMIDAZOLILO COMPOUNDS
ECSP077259A (en) PIRIMIDINE DERIVATIVES
ECSP055676A (en) HETEROCYCLIC PIPERAZINAS REPLACED FOR THE TREATMENT OF CHICHOPHRENIA
UY28876A1 (en) SUBSTITUTED MORPHOLINE COMPOUNDS AND COMPOSITIONS FOR THE TREATMENT OF CENTRAL NERVOUS SYSTEM DISORDERS
ECSP10010419A (en) UREA HETEROCYCLIC DERIVATIVES AND METHODS OF USE OF THE SAME-211
CU20100159A7 (en) COMPOUNDS
DOP2006000076A (en) CYCLOPENTAPIRIDINE AND TETRAHYDROQUINOLINE DERIVATIVES
NI200900183A (en) PYRID [2,3-D] PYRIMIDINE - 7 - ONA COMPOUNDS AS PI3K - ALPHA INHIBITORS FOR THE TREATMENT OF CANCER.
UY32315A (en) PIPERIDINE COMPOUNDS AND USES OF THE SAME-596
NI200700032A (en) ARILSULFONYLESTILBEN DERIVATIVES FOR INSOMNIA TREATMENT AND RELATED AFFECTIONS
ECSP088584A (en) NEW DERIVATIVES OF BENZIMIDAZOL AS INHIBITORS OF VANILLOID RECEIVER 1 (VRL)
UY31141A1 (en) PIPERIDINE COMPOUNDS AND ITS USES
ECSP10010659A (en) HETEROCYCLIC DERIVATIVES OF UREA AND ITS EMPLOYMENT METHODS
UY31864A (en) DERIVATIVES OF UREA HETERICÍCLICA AND METHODS OF USE OF THE SAME-332

[8]ページ先頭

©2009-2025 Movatter.jp